Publications by authors named "Nana Mukuria"
Transgender women (TW) and men who have sex with men (MSM) in Kenya are disproportionately affected by human immunodeficiency virus (HIV) and would benefit substantially from pre-exposure prophylaxis (PrEP). We conducted focus group discussions (FGDs) with healthcare providers (HCPs) and TW/MSM leadership and in-depth interviews (IDIs) with PrEP-experienced MSM and TW to learn about perceived and actual barriers to PrEP programming. Eleven HCP and 10 TW/MSM leaders participated in FGDs before PrEP roll-out (January 2018) and 12 months later.
View Article and Find Full Text PDFBackground: Human immunodeficiency virus (HIV) partner notification services (HPN), peer mobilization with HIV self-testing, and acute and early HIV infection (AEHI) screening among gay, bisexual, and other men who have sex with men (GBMSM) and transgender women (TGW) were assessed for acceptability, feasibility, and linkage to antiretroviral therapy (ART) and preexposure prophylaxis (PrEP) services.
Methods: Between April and August 2019, peer mobilizers mobilized clients by offering HIV oral self-tests and immediate clinic referral for clients with AEHI symptoms. Mobilized participants received clinic-based rapid antibody testing and point-of-care HIV RNA testing.
Article Synopsis
- The study focused on transgender women (TGW) and men who have sex with men (MSM) in sub-Saharan Africa, assessing their adherence to daily PrEP (pre-exposure prophylaxis) for HIV prevention by measuring tenofovir-diphosphate (TFV-DP) levels.
- Out of 53 participants, TGW showed better adherence rates compared to MSM, with 62.5% having any detectable TFV-DP and 37.5% maintaining protective levels, while only 14.7% of MSM had any TFV-DP detected.
- Key motivations for using PrEP included a heightened understanding of its benefits among TGW and a response to risky sexual behaviors; however,